The global Cell Harvesting Systems market size is estimated at 12.98 billion USD with a CAGR of 15.3% during the forecasted period from 2021-2028.
The global Cell Harvesting Systems market size is estimated at 12.98 billion USD with a CAGR of 15.3% during the forecasted period from 2021-2028. The key factors driving the Cell Harvesting Systems market is attributed to rising occurrence of diseases and a large pool of geriatric population across the globe. In addition, rising investments for stem cell and regenerative medicine research along with thriving biotechnological segment are accelerating the growth of this market. A rise in healthcare expenditure majorly due to chronic diseases. Sedentary lifestyle, excessive smoking, high obese rate, etc. are some of the reasons for illness and death. As a result, stem cells are used to treat chronic illness and impel the demand for cell harvesting systems. Likewise, budding use of stem cells in regenerative medicine is increasing a demand for stem cell research. Also, noteworthy upsurge in the stem cell transplantation rateis another chief driver for growing demand globally. Moreover, growing stem sell banking is positively impacting the market during the forecast period. On the other hand, factor such as high cost and lack of skilled professionals are expected to limit the market growth. Also, incidences like immune rejection can pose a threat to the market size. Cell harvesting is a process, in which stem cells are collected for the transplant or repairing the damaged organ with healthy functioning. The downstream related processes and biopharmaceutical industry are mainly dependent on cell harvesting techniques. A number of bio-pharma companies are manufacturing regenerating medicines by cell grafting method. Cell harvester plays a vital role in treating numerous types of diseases such as cancers, immune-deficiency related diseases and blood-related disorder. The cell harvesting system market is driven by rise in stem cell research, increase in stem cell transplantation and increasing cardiovascular diseases. However, ethical issues related to embryonic stem cells and unapproved stem cell therapy are the major factors restraining the cell harvesting system market growth. Expansion is a major strategy adopted by the key market players of cell harvesting system market.
Table of Content